SCHEMBL25412804

SCHEMBL25412804

Cc1ccc(S(=O)(=O)NN=C2CC3(CCN(C(=O)O)C3)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.47
HPGD P15428 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
GLA P06280 1/20 0.38
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
ALOX12 P18054 1/20 0.38
NFKB1 P19838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25410750 0.88 ALDH1A1 (0.48) ALDH1A1HPGDNPSR1F2PRSS1
SCHEMBL26631310 0.85 MEN1 (0.46) ALDH1A1KMT2AMEN1
SCHEMBL28527952 0.81 KMT2A (0.50) ALDH1A1KMT2AMEN1
SCHEMBL18824341 0.79 ALDH1A1 (0.62) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL25252374 0.79 ALDH1A1 (0.52) ALDH1A1HPGDF2PRSS1PRSS2
SCHEMBL30498701 0.78 ALDH1A1 (0.56) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL26738584 0.78 KMT2A (0.47) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL21815402 0.77 ALDH1A1 (0.57) ALDH1A1HPGDF2PRSS1PRSS2
SCHEMBL25339246 0.77 ALDH1A1 (0.57) ALDH1A1HPGDF2PRSS1PRSS2
SCHEMBL1250614 0.76 ALDH1A1 (0.53) ALDH1A1HPGDF2PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208902-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-06-27 US disclosed
US-11802111-B2 Cyclobutyl amide monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-10-31 US disclosed
EP-4217062-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-08-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208902-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS MGLL, LPL, PNLIP ALDH1A1 472/4885HPGD 1997/4885NPSR1 123/4885
US-11802111-B2 Cyclobutyl amide monoacylglycerol lipase modulators MGLL, LPL, PNLIP ALDH1A1 450/4885HPGD 1955/4885NPSR1 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.